L

L&C Bio Co Ltd
KOSDAQ:290650

Watchlist Manager
L&C Bio Co Ltd
KOSDAQ:290650
Watchlist
Price: 60 500 KRW 0.83% Market Closed
Market Cap: 1.5T KRW

Operating Margin
L&C Bio Co Ltd

2%
Current
10%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
2%
=
Operating Profit
1.6B
/
Revenue
80B

Operating Margin Across Competitors

No Stocks Found

L&C Bio Co Ltd
Glance View

Market Cap
1.5T KRW
Industry
Biotechnology

L&C BIO Co., Ltd. develops soft tissue, allografts, and medical devices. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-11-01. The firm mainly manufactures and sells human tissue transplant materials used for tissue repair and filler. The firm also produces and sells human tissue-based medical devices and Cosmeceuticals. Its products are used in vascular surgeries, plastic surgeries, general surgeries and others.

L&C Bio Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
2%
=
Operating Profit
1.6B
/
Revenue
80B
What is the Operating Margin of L&C Bio Co Ltd?

Based on L&C Bio Co Ltd's most recent financial statements, the company has Operating Margin of 2%.

Back to Top